Gerald Proehl Net Worth & Insider Trades

Gerald Proehl Tenax Therapeutics, Inc

As of June 10, 2022

What is Gerald Proehl's Net Worth?

The current estimated net worth of Tenax Therapeutics, Inc's Gerald Proehl is estimated to be about $316.81K . Gerald Proehl owns about 29,882 units of Tenax Therapeutics, Inc common stock. In the last 6 years at Tenax Therapeutics, Inc, Gerald Proehl has sold an estimated value of $0 worth.

What is Gerald Proehl's Past Insider Trading?

Gerald Proehl's largest purchase order was 29,882 units , worth over $49.97K on November 29, 2016. In total, Gerald Proehl has made about 5 transactions over 6 years of their time at Tenax Therapeutics, Inc. Gerald Proehl usually trades in June, with the busiest year in 2019, 2021, 2016, 2022 and 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GERALD PROEHL

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Tenax Therapeutics, Inc's Past Insider Trades?

Tenax Therapeutics, Inc's most recent insider trade came on September 9, 2020 by Armistice Capital Llc, Armistice Capital Master Fund Ltd and Steven Boyd who bought 32,000 units worth $45.55K . In the last 5 years, insiders at Tenax Therapeutics, Inc have sold an estimated value of $71.27K and bought an estimated value of $977.18K worth of shares. Insider trading is most common in June, with the busiest year in 2016. The most active traders at the company are Michael Jebsen, CFO,  Ronald R Blanck,  and Armistice Capital Llc, Director .

TENAX THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...